Design of a wideband multi-channel system for time reversal hyperthermia

Purpose: To design and test a wideband multi-channel amplifier system for time reversal (TR) microwave hyperthermia, operating in the frequency range 300 MHz–1 GHz, enabling operation in both pulsed and continuous wave regimes. This is to experimentally verify that adaptation of the heating pattern with respect to tumour size can be realised by varying the operating frequency of the antennas and potentially by using Ultra-wideband (UWB) pulse sequences instead of pure harmonic signals. Materials and methods: The proposed system consists of 12 identical channels driven by a common reference signal. The power and phase settings are applied with resolutions of 0.1 W and 0.1°, respectively. Using a calibration procedure, the measured output characteristics of each channel are interpolated using polynomial functions, which are then implemented into a system software algorithm driving the system feedback loop. Results: The maximum output power capability of the system varies with frequency, between 90 and 135 W with a relative power error of ±6%. A phase error in the order of ±4° has been achieved within the entire frequency band. Conclusions: The developed amplifier system prototype is capable of accurate power and phase delivery, over the entire frequency band of the system. The output power of the present system allows for an experimental verification of a recently developed TR-method on phantoms or animals. The system is suitable for further development for head and neck tumours, breast or extremity applications.

[1]  Z Rijnen,et al.  The clinical feasibility of deep hyperthermia treatment in the head and neck: new challenges for positioning and temperature measurement , 2010, Physics in medicine and biology.

[2]  S L George,et al.  Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment. , 1993, International journal of radiation oncology, biology, physics.

[3]  S. B. Field,et al.  The relationship between heating time and temperature: its relevance to clinical hyperthermia. , 1983, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  Gary L. Rosner,et al.  A phase II trial testing the thermal dose parameter CEM43 degrees T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy. , 2001, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[5]  Zeljko Vujaskovic,et al.  Randomized trial of hyperthermia and radiation for superficial tumors. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  M. Amichetti,et al.  Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes: a prospective randomized clinical trial. , 1987, International journal of radiation oncology, biology, physics.

[7]  Jan Vrba,et al.  Time-reversal focusing in microwave hyperthermia for deep-seated tumors , 2010, Physics in medicine and biology.

[8]  Peter Wust,et al.  Hyperthermia classic commentary: ‘Simulation studies promote technological development of radiofrequency phased array hyperthermia’ by Peter Wust et al., International Journal of Hyperthermia 1996;12:477–494 , 2009, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[9]  P. J. Hoopes,et al.  Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia , 2003, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[10]  Margarethus M. Paulides,et al.  A head and neck hyperthermia applicator: Theoretical antenna array design , 2007, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[11]  Mikael Persson,et al.  Evaluation of a patch antenna applicator for time reversal hyperthemia , 2010, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[12]  J. Crezee,et al.  Improving locoregional hyperthermia delivery using the 3-D controlled AMC-8 phased array hyperthermia system: A preclinical study , 2009, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[13]  E. Neufeld,et al.  The HYPERcollar: A novel applicator for hyperthermia in the head and neck , 2007 .

[14]  P. Turner,et al.  BSD-2000 approach for deep local and regional hyperthermia: clinical utility. , 1989, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[15]  Liyong Wu,et al.  An RF phased array applicator designed for hyperthermia breast cancer treatments , 2006, Physics in medicine and biology.

[16]  P Wust,et al.  Design and test of a new multi-amplifier system with phase and amplitude control. , 1998, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[17]  Waldemar Wlodarczyk,et al.  Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia , 2006, Cancer.

[18]  A. Hart,et al.  Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial , 2000, The Lancet.

[19]  B. D. Veen,et al.  A computational study of ultra-wideband versus narrowband microwave hyperthermia for breast cancer treatment , 2006, IEEE transactions on microwave theory and techniques.

[20]  H. Schippers,et al.  Design and test of a 434 MHz multi-channel amplifier system for targeted hyperthermia applicators , 2010, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[21]  A. Hart,et al.  Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial , 2000, The Lancet.

[22]  P Wust,et al.  Electromagnetic phased arrays for regional hyperthermia: optimal frequency and antenna arrangement. , 2001, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[23]  Chieko Azuma,et al.  Using units of CEM 43°C T90, local hyperthermia thermal dose can be delivered as prescribed , 2000 .

[24]  J Kongsli,et al.  Evaluation of power and phase accuracy of the BSD Dodek amplifier for regional hyperthermia using an external vector voltmeter measurement system , 2006, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[25]  J. Lagendijk,et al.  Regional hyperthermia applicator design using FDTD modelling. , 2001, Physics in medicine and biology.

[26]  M. Amichetti,et al.  Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. , 1994, International journal of radiation oncology, biology, physics.

[27]  D Machin,et al.  Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. , 1996, International journal of radiation oncology, biology, physics.

[28]  K D Paulsen,et al.  Optimization of pelvic heating rate distributions with electromagnetic phased arrays. , 1999, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[29]  Svein Jacobsen,et al.  Reduction of hot spots in hyperthermia by means of broadband energy transmission , 1998 .

[30]  R. L. Levin,et al.  A three-dimensional thermal and electromagnetic model of whole limb heating with a MAPA , 1991, IEEE Transactions on Biomedical Engineering.

[31]  J. Overgaard,et al.  Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma , 1995, The Lancet.

[32]  Peter Wust,et al.  Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. , 2010, The Lancet. Oncology.